Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2025 Earnings Call Transcript May 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.50273 EPS, expectations ...
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 25,074 calls trading, 1.6x expected, and implied vol increasing almost 21 points to 129.29%. Sep-25 7 calls and Sep-25 9 calls are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback